21755005|t|Lack of LDL receptor enhances amyloid deposition and decreases glial response in an Alzheimer's disease mouse model.
21755005|a|BACKGROUND: Apolipoprotein E (ApoE), a cholesterol carrier associated with atherosclerosis, is a major risk factor for Alzheimer's disease (AD). The low-density lipoprotein receptor (LDLR) regulates ApoE levels in the periphery and in the central nervous system. LDLR has been identified on astrocytes and a number of studies show that it modulates amyloid deposition in AD transgenic mice. However these findings are controversial on whether LDLR deletion is beneficial or detrimental on the AD-like phenotype of the transgenic mice. METHODOLOGY/PRINCIPAL FINDINGS: To investigate the role of LDLR in the development of the amyloid related phenotype we used an APP/PS1 transgenic mouse (5XFAD) that develops an AD-like pathology with amyloid plaques, astrocytosis and microgliosis. We found that 4 months old 5XFAD transgenic mice on the LDLR deficient background (LDLR-/-) have increased amyloid plaque deposition. This increase is associated with a significant decrease in astrocytosis and microgliosis in the 5XFAD/LDLR-/- mice. To further elucidate the role of LDLR in relation with ApoE we have generated 5XFAD transgenic mice on the ApoE deficient (ApoE-/-) or the ApoE/LDLR double deficient background (ApoE-/-/LDLR -/-). We have found that ApoE deletion in the 4 months old 5XFAD/ApoE-/- mice decreases amyloid plaque formation as expected, but has no effect on astrocytosis or microgliosis. By comparison 5XFAD/ApoE-/-LDLR -/- double deficient mice of the same age have increased amyloid deposition with decreased astrocytosis and microgliosis. CONCLUSIONS: Our analysis shows that LDL deficiency regulates astrocytosis and microgliosis in an AD mouse model. This effect is independent of ApoE, as both 5XFAD/LDLR -/- and 5XFAD/ApoE-/- LDLR -/- mice show reduction in inflammatory response and increase in amyloid deposition compared to control mice. These results demonstrate that LDLR regulates glial response in this mouse model independently of ApoE and modifies amyloid deposition.
21755005	8	20	LDL receptor	Gene	16835
21755005	30	48	amyloid deposition	Disease	MESH:D058225
21755005	84	103	Alzheimer's disease	Disease	MESH:D000544
21755005	104	109	mouse	Species	10090
21755005	129	145	Apolipoprotein E	Gene	11816
21755005	147	151	ApoE	Gene	11816
21755005	156	167	cholesterol	Chemical	MESH:D002784
21755005	192	207	atherosclerosis	Disease	MESH:D050197
21755005	236	255	Alzheimer's disease	Disease	MESH:D000544
21755005	257	259	AD	Disease	MESH:D000544
21755005	266	298	low-density lipoprotein receptor	Gene	16835
21755005	300	304	LDLR	Gene	16835
21755005	316	320	ApoE	Gene	11816
21755005	380	384	LDLR	Gene	16835
21755005	466	484	amyloid deposition	Disease	MESH:D058225
21755005	488	490	AD	Disease	MESH:D000544
21755005	502	506	mice	Species	10090
21755005	560	564	LDLR	Gene	16835
21755005	610	612	AD	Disease	MESH:D000544
21755005	646	650	mice	Species	10090
21755005	711	715	LDLR	Gene	16835
21755005	742	749	amyloid	Disease	MESH:C000718787
21755005	783	786	PS1	Gene	19164
21755005	798	803	mouse	Species	10090
21755005	805	810	5XFAD	Disease	
21755005	829	831	AD	Disease	MESH:D000544
21755005	852	867	amyloid plaques	Disease	MESH:D058225
21755005	869	881	astrocytosis	Disease	MESH:D005911
21755005	886	898	microgliosis	Disease	
21755005	927	932	5XFAD	Disease	
21755005	944	948	mice	Species	10090
21755005	956	960	LDLR	Gene	16835
21755005	983	987	LDLR	Gene	16835
21755005	1007	1032	amyloid plaque deposition	Disease	MESH:D058225
21755005	1093	1105	astrocytosis	Disease	MESH:D005911
21755005	1110	1122	microgliosis	Disease	
21755005	1130	1135	5XFAD	Disease	
21755005	1136	1140	LDLR	Gene	16835
21755005	1144	1148	mice	Species	10090
21755005	1183	1187	LDLR	Gene	16835
21755005	1205	1209	ApoE	Gene	11816
21755005	1228	1233	5XFAD	Disease	
21755005	1245	1249	mice	Species	10090
21755005	1257	1261	ApoE	Gene	11816
21755005	1273	1277	ApoE	Gene	11816
21755005	1289	1293	ApoE	Gene	11816
21755005	1294	1298	LDLR	Gene	16835
21755005	1328	1332	ApoE	Gene	11816
21755005	1336	1340	LDLR	Gene	16835
21755005	1366	1370	ApoE	Gene	11816
21755005	1400	1405	5XFAD	CellLine	CVCL:5U93
21755005	1406	1410	ApoE	Gene	11816
21755005	1414	1418	mice	Species	10090
21755005	1429	1443	amyloid plaque	Disease	MESH:D058225
21755005	1488	1500	astrocytosis	Disease	MESH:D005911
21755005	1504	1516	microgliosis	Disease	
21755005	1532	1537	5XFAD	Disease	
21755005	1538	1542	ApoE	Gene	11816
21755005	1545	1549	LDLR	Gene	16835
21755005	1571	1575	mice	Species	10090
21755005	1607	1625	amyloid deposition	Disease	MESH:D058225
21755005	1641	1653	astrocytosis	Disease	MESH:D005911
21755005	1658	1670	microgliosis	Disease	
21755005	1709	1723	LDL deficiency	Disease	MESH:D006938
21755005	1734	1746	astrocytosis	Disease	MESH:D005911
21755005	1751	1763	microgliosis	Disease	
21755005	1770	1772	AD	Disease	MESH:D000544
21755005	1773	1778	mouse	Species	10090
21755005	1816	1820	ApoE	Gene	11816
21755005	1830	1835	5XFAD	Disease	
21755005	1836	1840	LDLR	Gene	16835
21755005	1849	1854	5XFAD	Disease	
21755005	1855	1859	ApoE	Gene	11816
21755005	1863	1867	LDLR	Gene	16835
21755005	1872	1876	mice	Species	10090
21755005	1895	1907	inflammatory	Disease	MESH:D007249
21755005	1933	1951	amyloid deposition	Disease	MESH:D058225
21755005	1972	1976	mice	Species	10090
21755005	2009	2013	LDLR	Gene	16835
21755005	2047	2052	mouse	Species	10090
21755005	2076	2080	ApoE	Gene	11816
21755005	2094	2112	amyloid deposition	Disease	MESH:D058225
21755005	Association	11816	16835
21755005	Association	MESH:D000544	16835
21755005	Association	MESH:D005911	16835
21755005	Association	MESH:D006938	16835
21755005	Association	MESH:D058225	11816
21755005	Association	MESH:D050197	11816
21755005	Association	MESH:D000544	11816
21755005	Association	MESH:D058225	16835

